Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk
KC Simon, IAF van der Mei, KL Munger, A Ponsonby, J Dickinson, T Dwyer, P Sundstroem, A Ascherio
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2010
Awarded by NIH/NINDS
Awarded by NIH Kirschstein
Study funding: Supported by the NIH/NINDS R01 NS47467, the National Health and Research Council (NHMRC) of Australia, the Australian Rotary Health Research Fund, and MS Australia. Dr. Simon is supported by NIH Kirschstein-NRSA T32 ES016645-01. Dr van der Mei is supported by an NHMRC Training and her work was supported by a Du Pre grant from the MS International Federation and a travel grant from the Ian Potter Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.